Riverwater Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Sell |
44,923
-5,091
| -10% | -$380K | 1.58% | 9 |
|
|
2025
Q1 | $3.18M | Sell |
50,014
-365
| -0.7% | -$23.2K | 1.63% | 9 |
|
|
2024
Q4 | $3.93M | Buy |
50,379
+5,538
| +12% | +$432K | 1.91% | 8 |
|
|
2024
Q3 | $3.56M | Buy |
44,841
+29,109
| +185% | +$2.31M | 1.77% | 10 |
|
|
2024
Q2 | $1.3M | Sell |
15,732
-73
| -0.5% | -$6.04K | 0.96% | 23 |
|
|
2024
Q1 | $1.35M | Buy |
15,805
+21
| +0.1% | +$1.79K | 0.99% | 22 |
|
|
2023
Q4 | $1.35M | Buy |
15,784
+231
| +1% | +$19.8K | 1.06% | 17 |
|
|
2023
Q3 | $1.39M | Sell |
15,553
-162
| -1% | -$14.5K | 1.27% | 13 |
|
|
2023
Q2 | $1.34M | Buy |
15,715
+4,499
| +40% | +$383K | 1.19% | 16 |
|
|
2023
Q1 | $928K | Buy |
11,216
+2,098
| +23% | +$174K | 0.85% | 25 |
|
|
2022
Q4 | $717K | Buy |
+9,118
| New | +$717K | 0.61% | 48 |
|